Phase I and II Trials of Vinorelbine With Carboplatin for Patients 75 Years of Age or Older With Previously Untreated Non–Small-Cell Lung Cancer
Tài liệu tham khảo
Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516
Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073
Owonikoko, 2007, Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database, J Clin Oncol, 25, 5570, 10.1200/JCO.2007.12.5435
Wingo, 2003, Long-term trends in cancer mortality in the United States, 1930-1998, Cancer, 97, 3133, 10.1002/cncr.11380
Azzoli, 2010, American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer, J Oncol Pract, 6, 39, 10.1200/JOP.091065
1999, Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer, J Natl Cancer Inst, 91, 66, 10.1093/jnci/91.1.66
Gridelli, 2003, Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial, J Natl Cancer Inst, 95, 362, 10.1093/jnci/95.5.362
Rose, 1985, Preclinical antitumor and toxicologic profile of carboplatin, Cancer Treat Rev, 12, 1, 10.1016/0305-7372(85)90014-3
1979
1999
Kudoh, 2006, Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904), J Clin Oncol, 24, 3657, 10.1200/JCO.2006.06.1044
Quoix, 2011, Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial, Lancet, 378, 1079, 10.1016/S0140-6736(11)60780-0
Abe, 2011, Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): an intergroup trial of JCOG0803/WJOG4307L, ASCO, 29
Gridelli, 2009, Treatment of advanced non-small-cell lung cancer in the elderly, Lung Cancer, 66, 282, 10.1016/j.lungcan.2009.08.006
Pallis, 2010, Is age a negative prognostic factor for the treatment of advanced/metastatic non-small-cell lung cancer?, Cancer Treat Rev, 36, 436, 10.1016/j.ctrv.2009.12.013
Fukuda, 2004, Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer, Cancer Chemother Pharmacol, 54, 573, 10.1007/s00280-004-0805-2